JW Asset Management

JW Asset Management is a New York-based investment firm that primarily invests within the healthcare sector. It runs 3 Hedge Funds and two Private Equity Funds. It has led the investor group in the 2010 acquisition of Arbor Pharmaceuticals, Inc. and more recently as the lead investors in TerrAscend Corp.

Jason Wild

President and Chief Investment Officer

22 past transactions

Tyson 2.0

Series A in 2022
Tyson 2.0 is a cannabis company producing cannabis products known for purity, precision, and wide accessibility. Providing consumers an outstanding selection of products, Tyson 2.0 is an extraordinary balance of premium and affordable, full-spectrum cannabis flower, concentrates, and consumables available at retailers nationwide. The company is formed by the legendary boxer, entrepreneur, and icon Mike Tyson.

Allumia

Series A in 2022
Allumia, LLC designs, funds, installs, and manages lighting upgrades. It evaluates the current lighting and follow-up with a proposal, which includes updated designs and expected savings; installs and upgrades the entire facility’s lighting; and provides replacement lamps, drivers, and additional lighting hardware; and maintenance services. The company serves commercial, athletic, automotive, and industrial markets. Allumia, LLC was founded in 2013 and is based in Seattle, Washington. It has additional satellite offices in Los Angeles, California and Durham, North Carolina.

Pistil Data

Seed Round in 2021
Pistil Data is a well-funded, early stage data technology startup. Founded by executives from Google, Twitter and Intel, Pistil Data is developing SaaS data services for one of the fastest growing industries in the world: cannabis. We are unique in our application of cutting-edge technology to an industry that has increasing needs for data and insight. Our goal is to be the leading data platform for cannabis, and help every cannabis business find new opportunities to grow.

Fyllo

Series C in 2021
Fyllo Inc. is a marketing technology company that specializes in serving the cannabis industry. Founded in 2019 and headquartered in Chicago, Illinois, with additional offices in major cities across North America and Israel, Fyllo offers a comprehensive platform designed to address the unique challenges of this highly regulated market. The Fyllo Compliance Cloud provides enterprise-grade software and services, leveraging RegsTechnology's extensive database of cannabis laws and regulations at various governmental levels. Fyllo's solutions encompass data analytics, ad campaign management, measurement and reporting, and creative management services, enabling marketers and legal professionals to navigate compliance complexities while driving growth and engagement.

CityRow

Series A in 2021
CityRow Holdings, Inc. specializes in health and fitness services, offering a unique blend of workouts that include yoga, strength training, and cardio, primarily utilizing water-based rowing machines. Founded in 2014 and headquartered in New York City, the company operates three locations in Michigan and New York. CityRow also provides a digital platform, Cityrow Go, which is a rowing-based fitness app designed for smartphones and tablets. This app features a variety of rowing classes aimed at delivering effective and motivating workouts for users at home. The studio's approach focuses on enhancing aerobic capacity and overall body efficiency through high-intensity interval training that emphasizes low-impact exercises, helping individuals achieve their fitness goals in a scientifically guided manner.

Fyllo

Series B in 2021
Fyllo Inc. is a marketing technology company that specializes in serving the cannabis industry. Founded in 2019 and headquartered in Chicago, Illinois, with additional offices in major cities across North America and Israel, Fyllo offers a comprehensive platform designed to address the unique challenges of this highly regulated market. The Fyllo Compliance Cloud provides enterprise-grade software and services, leveraging RegsTechnology's extensive database of cannabis laws and regulations at various governmental levels. Fyllo's solutions encompass data analytics, ad campaign management, measurement and reporting, and creative management services, enabling marketers and legal professionals to navigate compliance complexities while driving growth and engagement.

Gage Cannabis

Venture Round in 2020
Gage Cannabis Co. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market.

Fyllo

Series A in 2020
Fyllo Inc. is a marketing technology company that specializes in serving the cannabis industry. Founded in 2019 and headquartered in Chicago, Illinois, with additional offices in major cities across North America and Israel, Fyllo offers a comprehensive platform designed to address the unique challenges of this highly regulated market. The Fyllo Compliance Cloud provides enterprise-grade software and services, leveraging RegsTechnology's extensive database of cannabis laws and regulations at various governmental levels. Fyllo's solutions encompass data analytics, ad campaign management, measurement and reporting, and creative management services, enabling marketers and legal professionals to navigate compliance complexities while driving growth and engagement.

High 12

Series A in 2019
A brand is not simply a name. It is not just a logo or a website. A brand is an identifier of the larger community in which it resides. We build brands that bring people together, mark a common bond, and thread through the ties of shared social fabric.

Canndescent

Series C in 2019
Canndescent LLC is a cannabis cultivator based in Santa Barbara, California, specializing in the production of premium cannabis flowers. The company adheres to state compliance regulations and focuses on quality management and cultivation expertise. By moving away from traditional strain names, Canndescent aims to simplify the customer experience, offering products that are cultivated, packaged, and distributed in accordance with all relevant state and local laws.

Fyllo

Seed Round in 2019
Fyllo Inc. is a marketing technology company that specializes in serving the cannabis industry. Founded in 2019 and headquartered in Chicago, Illinois, with additional offices in major cities across North America and Israel, Fyllo offers a comprehensive platform designed to address the unique challenges of this highly regulated market. The Fyllo Compliance Cloud provides enterprise-grade software and services, leveraging RegsTechnology's extensive database of cannabis laws and regulations at various governmental levels. Fyllo's solutions encompass data analytics, ad campaign management, measurement and reporting, and creative management services, enabling marketers and legal professionals to navigate compliance complexities while driving growth and engagement.

Henry's Originals

Series B in 2019
Henry's Originals is a producer of handcrafted cannabis products from family-run farms in Mendocino County. Since launching in mid-2017, Henry’s Original has been featured in the Los Angeles Times, Mashable, SF Gate, Men’s Journal, LA Weekly, and Metro.

GrowGeneration

Post in 2019
GrowGeneration is a private company, whose plan is to open and operate hydroponic and specialty gardening stores and capitalize on the rapid growth from the legalization of marijuana and home gardening. The company is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems, and accessories for hydroponic gardening.

Vitruvias Therapeutics

Series A in 2018
Vitruvias Therapeutics is a start-up generic pharmaceutical company that will focus on developing niche topical generic products that are sold only by prescription. The name of the company is taken from Leonardo da Vinci’s drawing “The Vitruvian Man” which refers to the idealized proportionality of the human figure. The company was founded in 2013 and is based in Montgomery, Alabama.

TerrAscend

Post in 2017
TerrAscend is a vertically-integrated Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of the cannabis market. The Company provides support to patients through its wholly-owned subsidiaries, Solace Health Inc., a licensed producer of cannabis under the Access to Cannabis for Medical Purposes Regulations, and Terra Health Network Inc., a provider of clinical support and education programs led by health care professionals.

Vensun Pharmaceuticals

Series C in 2016
Vensun Pharmaceuticals is a pharmaceutical company based in Yardley, Pennsylvania, focused on developing generic prescription products across various dosage forms and therapeutic categories. Since its incorporation in 2011, Vensun has emerged as a notable player in the generic pharmaceutical market, having filed numerous Abbreviated New Drug Applications (ANDAs) with the FDA in collaboration with strategic partners. The company is actively engaged in the development of over 30 products, demonstrating its commitment to expanding its portfolio. Additionally, Vensun seeks further opportunities for partnerships and product acquisitions to enhance its development capabilities and meet the needs of clinicians and healthcare professionals in the United States.

Establishment Labs

Debt Financing in 2016
Establishment Labs is a medical technology company headquartered in Alajuela, Costa Rica, specializing in the design, development, manufacturing, and marketing of silicone-filled breast and body shaping implants, primarily under the Motiva Implants brand. The company offers a diverse range of breast implants with various options for surface, shape, size, base, and projection. In addition to implants, Establishment Labs provides advanced solutions such as the Divina 3D surgical simulation system for pre-surgical consultations and the Puregraft technology for autologous fat harvesting and redistribution. The company operates globally, selling its products through exclusive distributors and a direct sales force in over 80 countries, while maintaining compliance with both FDA and ISO standards. Establishment Labs emphasizes innovation and quality assurance throughout its manufacturing processes, ensuring that its products meet the highest safety and performance standards.

Establishment Labs

Venture Round in 2015
Establishment Labs is a medical technology company headquartered in Alajuela, Costa Rica, specializing in the design, development, manufacturing, and marketing of silicone-filled breast and body shaping implants, primarily under the Motiva Implants brand. The company offers a diverse range of breast implants with various options for surface, shape, size, base, and projection. In addition to implants, Establishment Labs provides advanced solutions such as the Divina 3D surgical simulation system for pre-surgical consultations and the Puregraft technology for autologous fat harvesting and redistribution. The company operates globally, selling its products through exclusive distributors and a direct sales force in over 80 countries, while maintaining compliance with both FDA and ISO standards. Establishment Labs emphasizes innovation and quality assurance throughout its manufacturing processes, ensuring that its products meet the highest safety and performance standards.
Aralez Pharmaceuticals operates as a pharmaceutical company. The Company focuses on acquiring, developing, and commercializing products primarily in cardiovascular, pain, and other specialty areas. Aralez Pharmaceuticals serves customers worldwide.

Vensun Pharmaceuticals

Series B in 2013
Vensun Pharmaceuticals is a pharmaceutical company based in Yardley, Pennsylvania, focused on developing generic prescription products across various dosage forms and therapeutic categories. Since its incorporation in 2011, Vensun has emerged as a notable player in the generic pharmaceutical market, having filed numerous Abbreviated New Drug Applications (ANDAs) with the FDA in collaboration with strategic partners. The company is actively engaged in the development of over 30 products, demonstrating its commitment to expanding its portfolio. Additionally, Vensun seeks further opportunities for partnerships and product acquisitions to enhance its development capabilities and meet the needs of clinicians and healthcare professionals in the United States.

Vensun Pharmaceuticals

Series A in 2012
Vensun Pharmaceuticals is a pharmaceutical company based in Yardley, Pennsylvania, focused on developing generic prescription products across various dosage forms and therapeutic categories. Since its incorporation in 2011, Vensun has emerged as a notable player in the generic pharmaceutical market, having filed numerous Abbreviated New Drug Applications (ANDAs) with the FDA in collaboration with strategic partners. The company is actively engaged in the development of over 30 products, demonstrating its commitment to expanding its portfolio. Additionally, Vensun seeks further opportunities for partnerships and product acquisitions to enhance its development capabilities and meet the needs of clinicians and healthcare professionals in the United States.

Arbor Pharmaceuticals

Series B in 2010
Arbor Pharmaceuticals, operates as a specialty pharmaceutical company focusing on pediatric medicine. It engages in licensing, developing, and commercializing late-stage products for common pediatric conditions. The company's products include ZINOTIC and ZINOTIC ES, which addresses Acute Otitis Externa; NEOTIC, an otic analgesic agent for the treatment of pain and inflammation associated with Acute Otitis Media; and XYLAREX for the dietary management of Recurrent Acute Otitis Media. Its products also include Pediaderm HC Complete Kit, which is specifically developed to treat, manage, and protect the skin of children with atopic dermatitis, commonly referred to as eczema. The company markets its products specialty sales forces in the United States. Arbor Pharmaceuticals, was founded in 2006 and is based in Raleigh, North Carolina.